Alector (ALEC) Cash & Equivalents (2018 - 2026)
Alector's (ALEC) quarterly Cash & Equivalents came in at $77.0 million in Q1 2026, up 102.68% year-on-year from $38.0 million in Q1 2025, and up 16.96% on a QoQ basis from $65.8 million in Q4 2025.
Alector (ALEC) Cash & Equivalents (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Cash & Equivalents data on file, last reported at $77.0 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents rose 102.68% year-over-year to $77.0 million in Q1 2026; TTM through Mar 2026 was $77.0 million, a 102.68% increase from a year earlier, with the FY2025 full-year figure at $65.8 million, up 99.27% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $77.0 million, up from $65.8 million in the prior quarter.
- Over the last five years, Cash & Equivalents for ALEC reached as high as $454.6 million in Q1 2022 and fell as low as $33.0 million in Q4 2024.
- Historically, Cash & Equivalents has averaged $115.4 million across 5 years, with a median of $76.5 million in 2025.
- On a YoY basis, Cash & Equivalents climbed as much as 310.67% in 2022 and fell as far as 64.33% in 2022.
- Year by year, Cash & Equivalents stood at $154.3 million in 2022, then tumbled by 51.69% to $74.6 million in 2023, then slumped by 55.71% to $33.0 million in 2024, then soared by 99.27% to $65.8 million in 2025, then increased by 16.96% to $77.0 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $77.0 million in Q1 2026, $65.8 million in Q4 2025, and $76.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | 76.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.96 Mn |
| Dec 31, 2025 | 65.80 Mn |
| Sep 30, 2025 | 76.50 Mn |
| Jun 30, 2025 | 44.77 Mn |
| Mar 31, 2025 | 37.97 Mn |
| Dec 31, 2024 | 33.02 Mn |
| Sep 30, 2024 | 37.16 Mn |
| Jun 30, 2024 | 47.55 Mn |
| Mar 31, 2024 | 72.55 Mn |
| Dec 31, 2023 | 74.56 Mn |
| Sep 30, 2023 | 101.96 Mn |
| Jun 30, 2023 | 131.54 Mn |
| Mar 31, 2023 | 195.56 Mn |
| Dec 31, 2022 | 154.32 Mn |
| Sep 30, 2022 | 184.23 Mn |
| Jun 30, 2022 | 172.27 Mn |
| Mar 31, 2022 | 454.62 Mn |
| Dec 31, 2021 | 329.15 Mn |
| Sep 30, 2021 | 516.53 Mn |
| Jun 30, 2021 | 125.71 Mn |